Results for: S2000-025測試 💫 S2000-025學習筆記 🌵 S2000-025最新題庫資源 👱 透過➡ www.newdumpspdf.com ️⬅️搜索➡ S2000-025 ️⬅️免費下載考試資料S2000-025考題資源

DMF: the Canadian MS patient experience

…ch remedies, such as bismuth subsalicylate or an H2 blocker. When asked to compare the side effect burden with DMF compared to injectable DMTs, 53% said the burden was less with DMF, 34% said it was about the same, and 13% said it was worse with DMF. A limitation of the survey was that respondents were self-selected DMF users. Prior MSology surveys have found that a majority of DMT-treated patients believe that their current therapy is the best tr…

Third failed trial for solanezumab in AD

…ally offset the adverse effects of longer forms (e.g. Aβ42). Thus, indiscriminately reducing all beta-amyloid forms may worsen cognition in patients with a low baseline beta-amyloid load (Geerts et al. Alzheimers Res Ther 2018;10:14; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC5797372/pdf/13195_2018_Article_343.pdf). As such, the authors offer the counterintuitive suggestion that amyloid-lowering agents may actually worsen cognition out…

ECTRIMS/EAN publish new MS treatment guidelines

…7751049). The groups identified 10 key questions, and issued a series of recommendations based on the level of evidence. The following is a summary of the groups’ recommendations. Therapeutic intervention 1- All DMDs should be prescribed only in centres with adequate infrastructure to provide proper patient monitoring, comprehensive assessment, detection of side effects and the capacity to address them promptly. 2- Clinically isolated syndrome: Of…

2017 U.S. drug approvals in neurology and psychiatry

…ients (Writing Group, et al. Lancet Neurol 2017;16:505-512). Adjuvanted, recombinant varicella zoster vaccine (Shingrix, GlaxoSmithKline): while not a neurology/psychiatry drug, zoster vaccines are becoming routine in the treatment of MS patients scheduled for a course of immunosuppressants. The vaccine was approved for the prevention of shingles in adults >50 years. Of interest is that it is a non-live vaccine, in contrast to Zostavax, a live-att…

Vortioxetine: Improved work productivity in adults with major depression

…(Schatzberg et al. J Clin Psychiatry 2014;75:1411-1418; free full text at www.psychiatrist.com/JCP/article/_layouts/ppp.psych.controls/BinaryViewer.ashx?Article=/jcp/article/Pages/2014/v75n12/v75n1209.aspx&Type=Article). In the study by Katona and colleagues, elderly subjects (mean age 70.6 years) treated with vortioxetine 5 mg/day showed improved processing speed, verbal learning and memory on cognitive testing (Katona 2012). The reference agent…